Burning Rock announces the completion of the Series C financing of RMB 850 million and strives to build an international leading tumor precision medicine brand

BALI, Indonesia and SHANGHAI, Feb. 14, 2019 -- (Healthcare Sales & Marketing Network) -- On February 14, 2019, Burning Rock held the signing ceremony and announced the closing of the Series C financing totaling RMB 850 million. The financing was led by GI... Diagnostics, Oncology, Venture Capital Burning Rock, precision medicine
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news